RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
193 hedge funds and large institutions have $644M invested in Revance Therapeutics, Inc. in 2023 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 74 increasing their positions, 49 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
28% less capital invested
Capital invested by funds: $893M → $644M (-$249M)
Holders
193
Holding in Top 10
2
Calls
$18M
Puts
$5.27M
Top Buyers
| 1 | +$10.2M | |
| 2 | +$7.21M | |
| 3 | +$6.26M | |
| 4 |
BlackRock
New York
|
+$6.12M |
| 5 |
Walleye Capital
New York
|
+$5.47M |
Top Sellers
| 1 | -$16.6M | |
| 2 | -$15.6M | |
| 3 | -$11.4M | |
| 4 |
DM
Deerfield Management
New York
|
-$9.98M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$8.71M |